Cue Biopharma (CUE) Return on Assets [ROA] (2018 - 2026)
Cue Biopharma's Return on Assets [ROA] was -279.62% in Q2 2026, down 154.52 percentage points from -125.10% a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Cue Biopharma came in at -72.72%, up 15.84 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -20.38 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -88.56% in FY2024 (-20.31 pp), -68.25% in FY2023 (-7.56 pp), -60.69% in FY2022 (-12.41 pp) and -48.28% in FY2021 (+4.06 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] in data going back to Q1 2018.
- Compared with a year earlier, Return on Assets [ROA] was higher in 1 of the last seven quarters, with an average year-over-year change of -37.69 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2025 (a gain of 35.89 percentage points); the worst was Q2 2026 (a drop of 154.52 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Cue Biopharma | 98.10 Mn | 18.47 Mn | - | -319.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -319.94% |
| Mar 31, 2026 | -52.82% |
| Dec 31, 2025 | -70.97% |
| Sep 30, 2025 | -104.16% |
| Jun 30, 2025 | -123.55% |
| Mar 31, 2025 | -149.08% |
| Dec 31, 2024 | -105.65% |
| Sep 30, 2024 | -102.39% |
| Jun 30, 2024 | -97.53% |
| Mar 31, 2024 | -86.48% |
| Dec 31, 2023 | -77.65% |
| Sep 30, 2023 | -72.93% |
| Jun 30, 2023 | -66.97% |
| Mar 31, 2023 | -60.02% |
| Dec 31, 2022 | -63.38% |
| Sep 30, 2022 | -58.24% |
| Jun 30, 2022 | -55.67% |
| Mar 31, 2022 | -52.74% |
| Dec 31, 2021 | -54.44% |
| Sep 30, 2021 | -55.71% |
API Access
Cue Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();